ArticleNature communications2026
Activity-guided substructure prioritization accelerates discovery of gut microbiota-derived immune-regulating metabolites.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Activity-guided substructure prioritization accelerates discovery of gut microbiota-derived immune-regulating metabolites.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Gut microbiota exert significant influences on host physiology through bioactive molecules such as indole derivatives. The characteristic aromatic heterocycle substructure shared among various indole derivatives is intrinsically associated with the activation of aryl hydrocarbon receptor (AhR), suggesting a potential structure-activity relationship (SAR). Here, we develop a substructure-activity relationship mass spectrometry pipeline aiming at elucidating SAR information encompassed within mass spectrometry data, further applying it to identify the unknown gut microbiome-derived, indole-like derivatives with AhR agonistic potential. A total of 22 metabolites exhibiting activity-related substructures are identified, four of which were previously uncharacterized. Notably, the discovered sulfonated and methylthiolated compounds represent two previously underexplored microbiome-mediated reactions. Subsequent assays validate their AhR agonistic activities and downstream immune regulatory effects in male mice. Overall, this study presents an exploratory framework for MS data mining focusing on activity-guided substructure prioritization, enabling the discovery of bioactive microbiota-derived molecules and distinct microbiome-mediated reactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.